In This Article:
As European markets navigate the challenges of new U.S. trade tariffs and mixed economic signals, investors are keeping a close eye on dividend stocks that offer stability and income potential. In such uncertain times, stocks with strong dividend yields can provide a reliable income stream, making them an attractive option for those looking to balance risk with reward in their portfolios.
Top 10 Dividend Stocks In Europe
| Name | Dividend Yield | Dividend Rating |
| Bredband2 i Skandinavien (OM:BRE2) | 5.00% | ★★★★★★ |
| Julius Bär Gruppe (SWX:BAER) | 4.66% | ★★★★★★ |
| Zurich Insurance Group (SWX:ZURN) | 4.39% | ★★★★★★ |
| Mapfre (BME:MAP) | 5.50% | ★★★★★★ |
| HEXPOL (OM:HPOL B) | 4.91% | ★★★★★★ |
| Cembra Money Bank (SWX:CMBN) | 4.29% | ★★★★★★ |
| Deutsche Post (XTRA:DHL) | 4.96% | ★★★★★★ |
| Rubis (ENXTPA:RUI) | 7.96% | ★★★★★★ |
| Banque Cantonale Vaudoise (SWX:BCVN) | 4.53% | ★★★★★★ |
| Swiss Re (SWX:SREN) | 4.21% | ★★★★★☆ |
Click here to see the full list of 242 stocks from our Top European Dividend Stocks screener.
Let's dive into some prime choices out of the screener.
Ebro Foods
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Ebro Foods, S.A. is a food company operating in Spain, the rest of Europe, the United States, Canada, and internationally with a market cap of €2.63 billion.
Operations: Ebro Foods generates its revenue primarily from its Rice Business, which accounts for €2.45 billion, and its Pasta Business, contributing €691.78 million.
Dividend Yield: 3.9%
Ebro Foods, S.A. offers a mixed dividend profile for investors. The company reported increased earnings with net income rising to €207.87 million for 2024, supporting its dividend payments through a reasonable payout ratio of 50.1%. However, despite trading at good value and analysts forecasting price growth, Ebro's dividends have been volatile over the past decade and yield is lower than top-tier Spanish market payers at 3.86%.
Biofarm
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Biofarm S.A. is a Romanian company involved in the manufacture and sale of medicines, with a market capitalization of RON670.05 million.
Operations: Biofarm S.A. generates revenue primarily from its Pharmaceuticals segment, which accounts for RON286.77 million.
Dividend Yield: 4.6%
Biofarm's dividend profile shows stability and reliability, with dividends per share consistently growing over the past decade. However, a high cash payout ratio of 125.2% indicates dividends are not well covered by free cash flows, though a low payout ratio of 38% suggests earnings coverage is sufficient. The dividend yield of 4.56% is lower than top-tier Romanian market payers. Recent affirmations announced an annual dividend of RON 0.0310 per share for September 2025 payment.